Dan began his career in 1982 with Arthur Andersen & Co. in San Francisco working primarily with large financial, manufacturing and communications companies. He was later chief financial officer of TXL Capital Group, a middle-market investment banking firm, and president of its NASD registered broker-dealer subsidiary.
As a principal in private equity firm Genstar Capital Partners for eight years, Dan was involved in the investment and management of more than $200 million in controlling equity investments as well as numerous bank financings and public debt and equity offerings, and represented the firm and its investors on portfolio company boards.
In 1997 Dan returned to his home town of Portland, Oregon where he became CFO of Tyler Encapsulations, a dietary supplements company where he developed a strategy that led to a recapitalization and consolidation with three similar companies and was appointed CFO of the resulting entity, Enzymatic Therapy Inc. He was also CFO of an Internet services company whose founders included Intel executives and CFO of a distributed generation company founded by former senior executives of PacifiCorp.
In 2002 Dan joined Glass & Associates, Inc., later acquired by Huron Consulting Group, where he was a restructuring, turnaround and crisis management advisor and interim executive. During this time Dan worked with businesses with annual sales ranging from less than $50 million to over $1.5 billion. Engagements included strategic and operational assessments, operational turnarounds, financial restructurings, debt financings, mergers and acquisitions and liquidations where he improved outcomes for stakeholders including secured and unsecured creditors, shareholders and employees.
Education, certifications and professional associations: